COSRX Sustains Double-Digit Sales Growth into Q2 After Distribution and Logistics Overhaul
Creatrip Team
a month ago
Korean derma-cosmetics brand COSRX reported continued sales growth from Q4 2025 through Q2 2026, achieving double-digit increases and a record single-month high in May. The company attributes the rebound to stabilization of domestic and international pricing and completion of global distribution and logistics efficiency improvements. Strong performance was led by North America and Europe: in the U.S., sales of the peptide line rose alongside the established Snail line, while in Europe the new Ultra-Light Invisible Sun Serum topped SPF/ sunscreen categories on Amazon UK and Germany—signaling local consumer trust in a tightly regulated market. The brand says the addition of peptide and sun-serum lines has created new growth drivers and expects continued momentum in key overseas markets.
